Inexia Company
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.
Technology:
NeuroModulation
Industry:
NeuroTech
Headquarters:
London, England, United Kingdom
Founded Date:
2019
Employees Number:
1-10
Funding Status:
Seed
Register and Claim Ownership